News
Video
Podcasts
Journals
Conferences
Events
Resources
CE
About AJMC
Subscribe

Spotlight -

Free In-Person Regional Events Focused on Oncology and Population Health

|Articles|October 1, 2000

Supplements and Featured Publications

Antibody-Targeted Chemotherapy for the Treatment of Relapsed Acute Myeloid Leukemia
Volume 6
Issue 18 Suppl

Antibody-Targeted Chemotherapy for the Treatment of Relapsed Acute Myeloid Leukemia

Author(s)John P. Williams, MD, MBA, Heather L. Handler, MPH, MBA

Download PDF: Antibody-Targeted Chemotherapy for the Treatment of Relapsed Acute Myeloid Leukemia

Articles in this issue

over 25 years ago

Article

Commentary: New Research and Treatment Options for Acute Myeloid Leukemia

over 25 years ago

Article

Continuing Medical Education Quiz

over 25 years ago

Article

Overview: Treatment of Acute Myeloid Leukemia

Newsletter

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Latest CME

Innovations in Medicine: 2024 Lineup of New and Approved Specialty Drugs

Innovations in Medicine: 2024 Lineup of New and Approved Specialty Drugs

2.0 Credits / General Pharmacy

Revolutionizing Acute Pain Relief: Emerging Nonopioid Therapies and the Essential Role of Managed Care

AJMC Supplement

Revolutionizing Acute Pain Relief: Emerging Nonopioid Therapies and the Essential Role of Managed Care

2.0 Credits / Pain Management

Trending on AJMC

TrumpRx Launch Brings Savings—and Uncertainty

How Do GLP-1 Agonists Fit Into Stroke Care?

Addressing Disparities at Every Step of the Stroke Care Pathway: Luke Messac, MD, PhD

5 Things to Know About the Oral GLP-1 Era

Stroke Subtype Does Not Affect Efficacy of Asundexian for Second Stroke Prevention

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

© 2025 MJH Life Sciences^®

All rights reserved.

Alt Text

Alt Text